| Name | 4-({[(4-Methoxyphenyl)sulfonyl]oxy}imino)-2,6-dimethyl-2,5-cyclohexadien-1-one |
|---|---|
| Synonyms |
L002 (NSC764414) ,E0405
L002(NSC764414) 4-[O-[(4-Methoxyphenyl)sulfonyl]oxime]-2,6-dimethyl-2,5-cyclohexadiene-1,4-dione NSC764414 p300/CBP Inhibitor VI, L002 - - Calbiochem p300/CBP Inhibitor VI, L002 [(3,5-dimethyl-4-oxo-cyclohexa-2,5-dien-1-ylidene)amino] 4-methoxybenzenesulfonate 2,5-Cyclohexadiene-1,4-dione, 2,6-dimethyl-, 4-[O-[(4-methoxyphenyl)sulfonyl]oxime] L 002;NSC 764414;L-002;NSC-764414 L002, 10 mM in DMSO p300,acetylation,L 002,Inhibitor,HATs,L-002,HAT,inhibit,fibrosis,L002,Histone Acetyltransferase,STAT,cdiac,histone 4-({[(4-Methoxyphenyl)sulfonyl]oxy}imino)-2,6-dimethylcyclohexa-2,5-dien-1-one |
| Description | L002 is a novel potent, specific acetyltransferase p300 (KAT3B) inhibitor with an IC50 of 1.98 uM. L002 has weak inhibitory effects against PCAF and GCN5 (IC50s =35 and 34 µM, respectively) and is specific for p300 over a panel of additional acetyltransferases, deacetylases, and methyltransferases[1]. L002 blocks histone acetylation and p53 acetylation, and inhibits STAT3 activation[2]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.98 uM (KAT3B); 35 µM (PCAF); 34 µM (GCN5)[1] ;STAT3; p53[2] |
| References |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 459.8±55.0 °C at 760 mmHg |
| Molecular Formula | C15H15NO5S |
| Molecular Weight | 321.348 |
| Flash Point | 231.9±31.5 °C |
| Exact Mass | 321.067108 |
| LogP | 4.06 |
| Vapour Pressure | 0.0±1.1 mmHg at 25°C |
| Index of Refraction | 1.574 |
| RIDADR | NONH for all modes of transport |
|---|